A carregar...
Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease
BACKGROUND: Continuous erythropoiesis receptor activator (CERA) is a newer, longer acting ESA which might be preferred to other ESAs (epoetin or darbepoetin) based on its lower frequency of administration. Different dosing requirements and molecular characteristics of CERA compared with other ESAs m...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2017
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483666/ https://ncbi.nlm.nih.gov/pubmed/28782299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009904.pub2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|